Stockreport

Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting [Yahoo! Finance]

Artivion, Inc.  (AORT) 
PDF 2-Year Data from the AMDS PERSEVERE IDE Trial Further Demonstrate the Persistent Clinical Benefit of AMDS ATLANTA Feb. 2, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: A [Read more]